Vanguard Group’s bluebird bio BLUE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-518,238
| Closed | -$2.53M | – | 4282 |
|
|
2025
Q1 | $2.53M | Sell |
518,238
-7,176
| -1% | -$43.2K | ﹤0.01% | 3416 |
|
|
2024
Q4 | $4.38M | Buy |
525,414
+1,714
| +0.3% | +$15K | ﹤0.01% | 3323 |
|
|
2024
Q3 | $5.45M | Buy |
523,700
+8,635
| +2% | +$144K | ﹤0.01% | 3242 |
|
|
2024
Q2 | $10.1M | Sell |
515,065
-9,858
| -2% | -$197K | ﹤0.01% | 2909 |
|
|
2024
Q1 | $13.4M | Buy |
524,923
+86,154
| +20% | +$2.21M | ﹤0.01% | 2798 |
|
|
2023
Q4 | $12.1M | Buy |
438,769
+157,896
| +56% | +$9.63M | ﹤0.01% | 2841 |
|
|
2023
Q3 | $17.1M | Buy |
280,873
+2,311
| +0.8% | +$162K | ﹤0.01% | 2605 |
|
|
2023
Q2 | $18.3M | Buy |
278,562
+7,448
| +3% | +$545K | ﹤0.01% | 2628 |
|
|
2023
Q1 | $17.2M | Buy |
271,114
+57,798
| +27% | +$6.6M | ﹤0.01% | 2652 |
|
|
2022
Q4 | $29.5M | Buy |
213,316
+27,836
| +15% | +$3.92M | ﹤0.01% | 2442 |
|
|
2022
Q3 | $23.5M | Buy |
185,480
+10,135
| +6% | +$1.15M | ﹤0.01% | 2559 |
|
|
2022
Q2 | $14.5M | Sell |
175,345
-121,033
| -41% | -$9.39M | ﹤0.01% | 2795 |
|
|
2022
Q1 | $28.7M | Sell |
296,378
-65,302
| -18% | -$8.62M | ﹤0.01% | 2583 |
|
|
2021
Q4 | $72.3M | Sell |
361,680
-185,607
| -34% | -$43.8M | ﹤0.01% | 2147 |
|
|
2021
Q3 | $135M | Buy |
547,287
+9,892
| +2% | +$2.83M | ﹤0.01% | 1812 |
|
|
2021
Q2 | $223M | Buy |
537,395
+12,627
| +2% | +$5M | 0.01% | 1565 |
|
|
2021
Q1 | $205M | Buy |
524,768
+25,806
| +5% | +$12.7M | 0.01% | 1564 |
|
|
2020
Q4 | $280M | Buy |
498,962
+10,963
| +2% | +$6.95M | 0.01% | 1251 |
|
|
2020
Q3 | $341M | Buy |
487,999
+17,306
| +4% | +$13.5M | 0.01% | 951 |
|
|
2020
Q2 | $372M | Buy |
470,693
+171,463
| +57% | +$129M | 0.01% | 896 |
|
|
2020
Q1 | $178M | Buy |
299,230
+8,081
| +3% | +$7.88M | 0.01% | 1199 |
|
|
2019
Q4 | $331M | Sell |
291,149
-829
| -0.3% | -$901K | 0.01% | 1072 |
|
|
2019
Q3 | $347M | Sell |
291,978
-1,993
| -0.7% | -$3.04M | 0.01% | 987 |
|
|
2019
Q2 | $484M | Sell |
293,971
-83,747
| -22% | -$145M | 0.02% | 814 |
|
|
2019
Q1 | $770M | Buy |
377,718
+7,424
| +2% | +$13.1M | 0.03% | 589 |
|
|
2018
Q4 | $476M | Buy |
370,294
+13,675
| +4% | +$21M | 0.02% | 730 |
|
|
2018
Q3 | $674M | Buy |
356,619
+32,646
| +10% | +$67.4M | 0.03% | 661 |
|
|
2018
Q2 | $659M | Buy |
323,973
+1,680
| +0.5% | +$3.83M | 0.03% | 643 |
|
|
2018
Q1 | $713M | Buy |
322,293
+9,395
| +3% | +$23.9M | 0.03% | 608 |
|
|
2017
Q4 | $722M | Buy |
312,898
+28,502
| +10% | +$57.9M | 0.03% | 603 |
|
|
2017
Q3 | $506M | Buy |
284,396
+9,633
| +4% | +$13.5M | 0.02% | 718 |
|
|
2017
Q2 | $374M | Buy |
274,763
+26,546
| +11% | +$32M | 0.02% | 840 |
|
|
2017
Q1 | $292M | Buy |
248,217
+10,908
| +5% | +$11.1M | 0.02% | 978 |
|
|
2016
Q4 | $190M | Buy |
237,309
+26,110
| +12% | +$20.7M | 0.01% | 1206 |
|
|
2016
Q3 | $185M | Buy |
211,199
+4,236
| +2% | +$3.07M | 0.01% | 1160 |
|
|
2016
Q2 | $116M | Buy |
206,963
+25,738
| +14% | +$14.6M | 0.01% | 1418 |
|
|
2016
Q1 | $99.8M | Sell |
181,225
-1,861
| -1% | -$1.14M | 0.01% | 1486 |
|
|
2015
Q4 | $152M | Buy |
183,086
+13,487
| +8% | +$13.5M | 0.01% | 1170 |
|
|
2015
Q3 | $188M | Buy |
169,599
+9,381
| +6% | +$17.1M | 0.01% | 1024 |
|
|
2015
Q2 | $349M | Buy |
160,218
+53,147
| +50% | +$108M | 0.02% | 742 |
|
|
2015
Q1 | $167M | Buy |
107,071
+47,741
| +80% | +$63M | 0.01% | 1137 |
|
|
2014
Q4 | $70.5M | Buy |
59,330
+10,874
| +22% | +$7.27M | 0.01% | 1651 |
|
|
2014
Q3 | $22.5M | Buy |
48,456
+17,429
| +56% | +$8.04M | ﹤0.01% | 2156 |
|
|
2014
Q2 | $15.5M | Buy |
31,027
+13,828
| +80% | +$4.43M | ﹤0.01% | 2308 |
|
|
2014
Q1 | $5.07M | Buy |
17,199
+7,640
| +80% | +$2.31M | ﹤0.01% | 2820 |
|
|
2013
Q4 | $2.6M | Buy |
9,559
+1,459
| +18% | +$408K | ﹤0.01% | 3092 |
|
|
2013
Q3 | $2.83M | Buy |
+8,100
| New | +$3.01M | ﹤0.01% | 3003 |
|
Other funds holding BLUE
Vanguard Group's BLUE Position: Q2 2025 in Review
Vanguard Group sold out of bluebird bio (BLUE) in Q2 2025, closing a stake of 518,238 shares — an estimated $2.53M sold.
Vanguard Group first reported a position in BLUE in Q3 2013 and held it in 47 quarters. The position peaked at $770M in Q1 2019. 3 funds tracked by Wall St. Rank hold BLUE as of Q2 2025.
- Vanguard Group reported no remaining bluebird bio position as of Q2 2025 after selling out during the quarter.
- Vanguard Group sold 518,238 bluebird bio shares in Q2 2025, an estimated $2.53M.
- Vanguard Group first reported a position in bluebird bio in Q3 2013 and held it in 47 quarters.
- Vanguard Group's bluebird bio position peaked at $770M in Q1 2019.
- 3 funds tracked by Wall St. Rank held bluebird bio as of Q2 2025.
Based on Vanguard Group's 13F filing for Q2 2025, filed 11 Aug 2025.